-
Something wrong with this record ?
Scale-up from batch to flow-through wet milling process for injectable depot formulation
R. Lehocký, D. Pěček, F. Štěpánek,
Language English Country Netherlands
Document type Journal Article
- MeSH
- Chemistry, Pharmaceutical methods MeSH
- Injections MeSH
- Delayed-Action Preparations administration & dosage chemical synthesis MeSH
- Nanoparticles chemistry MeSH
- Solubility MeSH
- Suspensions MeSH
- Particle Size MeSH
- Publication type
- Journal Article MeSH
Injectable depot formulations are aimed at providing long-term sustained release of a drug into systemic circulation, thus reducing plasma level fluctuations and improving patient compliance. The particle size distribution of the formulation in the form of suspension is a key parameter that controls the release rate. In this work, the process of wet stirred media milling (ball milling) of a poorly water-soluble substance has been investigated with two main aims: (i) to determine the parametric sensitivity of milling kinetics; and (ii) to develop scale-up methodology for process transfer from batch to flow-through arrangement. Ball milling experiments were performed in two types of ball mills, a batch mill with a 30ml maximum working volume, and a flow-through mill with a 250ml maximum working volume. Milling parameters were investigated in detail by methodologies of QbD to map the parametric space. Specifically, the effects of ball size, ball fill level, and rpm on the particle breakage kinetics were systematically investigated at both mills, with an additional parameter (flow-rate) in the case of the flow-through mill. The breakage rate was found to follow power-law kinetics with respect to dimensionless time, with an asymptotic d50 particle size in the range of 200-300nm. In the case of the flow-through mill, the number of theoretical passes through the mill was found to be an important scale-up parameter.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023748
- 003
- CZ-PrNML
- 005
- 20170720123148.0
- 007
- ta
- 008
- 170720s2016 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejps.2016.08.043 $2 doi
- 035 __
- $a (PubMed)27568853
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Lehocký, Róbert $u Department of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic; Zentiva, k.s., U Kabelovny 130, 102 00 Praha 10, Czech Republic.
- 245 10
- $a Scale-up from batch to flow-through wet milling process for injectable depot formulation / $c R. Lehocký, D. Pěček, F. Štěpánek,
- 520 9_
- $a Injectable depot formulations are aimed at providing long-term sustained release of a drug into systemic circulation, thus reducing plasma level fluctuations and improving patient compliance. The particle size distribution of the formulation in the form of suspension is a key parameter that controls the release rate. In this work, the process of wet stirred media milling (ball milling) of a poorly water-soluble substance has been investigated with two main aims: (i) to determine the parametric sensitivity of milling kinetics; and (ii) to develop scale-up methodology for process transfer from batch to flow-through arrangement. Ball milling experiments were performed in two types of ball mills, a batch mill with a 30ml maximum working volume, and a flow-through mill with a 250ml maximum working volume. Milling parameters were investigated in detail by methodologies of QbD to map the parametric space. Specifically, the effects of ball size, ball fill level, and rpm on the particle breakage kinetics were systematically investigated at both mills, with an additional parameter (flow-rate) in the case of the flow-through mill. The breakage rate was found to follow power-law kinetics with respect to dimensionless time, with an asymptotic d50 particle size in the range of 200-300nm. In the case of the flow-through mill, the number of theoretical passes through the mill was found to be an important scale-up parameter.
- 650 _2
- $a farmaceutická chemie $x metody $7 D002626
- 650 _2
- $a léky s prodlouženým účinkem $x aplikace a dávkování $x chemická syntéza $7 D003692
- 650 _2
- $a injekce $7 D007267
- 650 _2
- $a nanočástice $x chemie $7 D053758
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a suspenze $7 D013535
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pěček, Daniel $u Zentiva, k.s., U Kabelovny 130, 102 00 Praha 10, Czech Republic.
- 700 1_
- $a Štěpánek, František $u Department of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. Electronic address: Frantisek.Stepanek@vscht.cz.
- 773 0_
- $w MED00001639 $t European journal of pharmaceutical sciences official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 95, č. - (2016), s. 122-129
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27568853 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170720123641 $b ABA008
- 999 __
- $a ok $b bmc $g 1239429 $s 984661
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 95 $c - $d 122-129 $e 20160826 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
- LZP __
- $a Pubmed-20170720